ROBERTO
RODRÍGUEZ JIMÉNEZ
Profesor asociado de Ciencias de la Salud
María Covadonga
Martínez Díaz Caneja
Publicaciones en las que colabora con María Covadonga Martínez Díaz Caneja (18)
2023
-
Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: The OPTiMiSE study
Psychological Medicine, Vol. 53, Núm. 8, pp. 3471-3479
-
Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study
The Journal of clinical psychiatry, Vol. 84, Núm. 2
-
Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120
2022
-
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia
Schizophrenia Research, Vol. 243, pp. 32-42
-
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
Schizophrenia, Vol. 8, Núm. 1
-
The effect of early life events on glucose levels in first-episode psychosis
Frontiers in Endocrinology, Vol. 13
-
The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis
Journal of Psychiatric Research, Vol. 155, pp. 171-179
2021
-
How does neighbourhood socio-economic status affect the interrelationships between functioning dimensions in first episode of psychosis? A network analysis approach
Health and Place, Vol. 69
-
Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients with a First Episode of Psychosis
Journal of Clinical Psychiatry, Vol. 82, Núm. 6
-
The interplay between functioning problems and symptoms in first episode of psychosis: An approach from network analysis
Journal of Psychiatric Research, Vol. 136, pp. 265-273
2020
-
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study
Schizophrenia Research, Vol. 218, pp. 292-294
-
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning
European Neuropsychopharmacology, Vol. 34, pp. 76-86
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort
Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552
2018
-
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807
-
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis
Schizophrenia Research, Vol. 193, pp. 188-196
-
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256
2016
-
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4
2014
-
Estudio farmacogenético del tratamiento a largo plazo con antipsicóticos de segunda generación y sus efectos adversos metabólicos (Estudio SLiM): justificación, objetivos, diseño y descripción de la muestra
Revista de Psiquiatria y Salud Mental, Vol. 7, Núm. 4, pp. 166-178